| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anasarca improved by extracorporeal ultrafiltration through an internal shunt in a case of severe haemophilia B with inhibitor and steroid-resistant nephrotic syndrome
|
SATOMURA, A.
|
|
2006
|
|
1 |
p. 103-105
|
artikel
|
| 2 |
A rapid multifluorescent polymerase chain reaction for genetic counselling in Chinese haemophilia A families
|
FANG, Y.
|
|
2006
|
|
1 |
p. 62-67
|
artikel
|
| 3 |
Canadian multi-institutional survey of immune tolerance therapy (ITT) – experience with the use of recombinant factor VIII for ITT
|
BARNES, C.
|
|
2006
|
|
1 |
p. 1-6
|
artikel
|
| 4 |
Combined clotting factor deficiencies: experience at a single hemophilia treatment center
|
O'BRIEN, S. H.
|
|
2007
|
|
1 |
p. 26-29
|
artikel
|
| 5 |
Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs
|
CARMASSI, F.
|
|
2007
|
|
1 |
p. 106-107
|
artikel
|
| 6 |
Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia
|
LINDVALL, K.
|
|
2006
|
|
1 |
p. 47-51
|
artikel
|
| 7 |
Confusion around the official classification of arthropathy
|
SCHULMAN, S.
|
|
2007
|
|
1 |
p. 117-119
|
artikel
|
| 8 |
Congenital factor VII deficiency: therapy with recombinant activated factor VII – a critical appraisal
|
MARIANI, G.
|
|
2006
|
|
1 |
p. 19-27
|
artikel
|
| 9 |
Considerations in the evaluation of haemophilia patients for short-term prophylactic therapy: a paediatric and adult case study
|
LUCHTMAN-JONES, L.
|
|
2006
|
|
1 |
p. 82-86
|
artikel
|
| 10 |
Cost minimization model for treatment of minor bleeding episodes in inhibitor patients – methodological issues
|
SEREMETIS, S.
|
|
2006
|
|
1 |
p. 108-109
|
artikel
|
| 11 |
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors
|
ASTERMARK, J.
|
|
2007
|
|
1 |
p. 38-45
|
artikel
|
| 12 |
Cyclosporin A can achieve immune tolerance in a patient with severe haemophilia B and refractory inhibitors
|
CROSS, D. C. A.
|
|
2007
|
|
1 |
p. 111-114
|
artikel
|
| 13 |
Deep vein thrombosis in a patient with severe haemophilia A
|
KASHYAP, R.
|
|
2006
|
|
1 |
p. 87-89
|
artikel
|
| 14 |
Defining ‘full-length’ recombinant factor VIII: a comparative structural analysis
|
JANKOWSKI, M. A.
|
|
2007
|
|
1 |
p. 30-37
|
artikel
|
| 15 |
Definitions for haemophilia prophylaxis and its outcomes: The Canadian Consensus Study
|
OTA, S.
|
|
2007
|
|
1 |
p. 12-20
|
artikel
|
| 16 |
Evaluation of pharmacokinetics, efficacy and safety of Immunate® solvent detergent in previously treated patients with severe haemophilia A
|
NEMES, L.
|
|
2007
|
|
1 |
p. 9-11
|
artikel
|
| 17 |
Force fluctuations during the Maximum Isometric Voluntary Contraction of the quadriceps femoris in haemophilic patients
|
GONZÁLEZ, L.-M.
|
|
2007
|
|
1 |
p. 65-70
|
artikel
|
| 18 |
Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill
|
PAYNE, J. H.
|
|
2007
|
|
1 |
p. 93-97
|
artikel
|
| 19 |
Haemophilia in Poland
|
WINDYGA, J.
|
|
2006
|
|
1 |
p. 52-57
|
artikel
|
| 20 |
Haemophilia: January 2007
|
Lee, Christine
|
|
2007
|
|
1 |
p. 1
|
artikel
|
| 21 |
Hepatitis C at the Israeli National Hemophilia Center
|
MAOR, Y.
|
|
2006
|
|
1 |
p. 68-74
|
artikel
|
| 22 |
Higher recovery of factor VIII (FVIII) with intermediate FVIII/von Willebrand factor concentrate than with recombinant FVIII in a haemophilia A patient with an inhibitor
|
INOUE, T.
|
|
2006
|
|
1 |
p. 110-113
|
artikel
|
| 23 |
IgE-mediated anaphylactic reaction to purified and recombinant factor VIII in a patient with severe haemophilia A
|
KADAR, J. G.
|
|
2007
|
|
1 |
p. 104-105
|
artikel
|
| 24 |
Impact of different inhibitor reactivities with commercial factor VIII concentrates on thrombin generation
|
SALVAGNO, G. L.
|
|
2007
|
|
1 |
p. 51-56
|
artikel
|
| 25 |
Inhibitor challenges in the paediatric setting
|
SIEGER, L.
|
|
2006
|
|
1 |
p. 106-107
|
artikel
|
| 26 |
In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting
|
BJÖRKMAN, S.
|
|
2007
|
|
1 |
p. 2-8
|
artikel
|
| 27 |
Long-term evaluation of radioisotope synovectomy with Yttrium 90 for chronic synovitis in Turkish haemophiliacs: Izmir experience
|
KAVAKLI, K.
|
|
2006
|
|
1 |
p. 28-35
|
artikel
|
| 28 |
Long-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding
|
COPPOLA, A.
|
|
2006
|
|
1 |
p. 90-94
|
artikel
|
| 29 |
Measuring patients’ perceptions on their functional abilities: validation of the Haemophilia Activities List
|
GENDEREN, F. R.
|
|
2006
|
|
1 |
p. 36-46
|
artikel
|
| 30 |
Monitoring the genotoxic effects of radiosynovectomy with Re-186 in paediatric age group undergoing therapy for haemophilic synovitis
|
TURKMEN, C.
|
|
2007
|
|
1 |
p. 57-64
|
artikel
|
| 31 |
Needles and needleless devices for infusion of anti-haemophilic factor concentrate: impact on protein structure and function
|
PRABHU, S.
|
|
2006
|
|
1 |
p. 58-61
|
artikel
|
| 32 |
Osteoporosis in haemophilia – an underestimated comorbidity?
|
WALLNY, T. A.
|
|
2007
|
|
1 |
p. 79-84
|
artikel
|
| 33 |
Pegylated interferon and ribavirin combination therapy for chronic hepatitis C in patients with congenital bleeding disorders: a single-centre experience
|
POSTHOUWER, D.
|
|
2007
|
|
1 |
p. 98-103
|
artikel
|
| 34 |
Practice patterns in haemophilia A therapy – global progress towards optimal care
|
GERAGHTY, S.
|
|
2006
|
|
1 |
p. 75-81
|
artikel
|
| 35 |
Prevalence of sporadic and familial haemophilia
|
KASPER, C. K.
|
|
2007
|
|
1 |
p. 90-92
|
artikel
|
| 36 |
Rituximab as an adjuvant therapy to immune tolerance in a haemophilia A boy with high inhibitor titre
|
CHUANSUMRIT, A.
|
|
2007
|
|
1 |
p. 108-110
|
artikel
|
| 37 |
Rituximab for congenital haemophiliacs with inhibitors: a Canadian experience
|
CARCAO, M.
|
|
2006
|
|
1 |
p. 7-18
|
artikel
|
| 38 |
Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy
|
FIELD, J. J.
|
|
2007
|
|
1 |
p. 46-50
|
artikel
|
| 39 |
Rituximab in the treatment of high responding inhibitors in severe haemophilia A
|
MOSCHOVI, M.
|
|
2006
|
|
1 |
p. 95-99
|
artikel
|
| 40 |
Short-term oral corticosteroid therapy for acute haemarthrosis in haemophilia patients with high-titre inhibitors
|
MEDEIROS, D.
|
|
2007
|
|
1 |
p. 85-89
|
artikel
|
| 41 |
Stayin' Alive
|
LIPTON, R. A.
|
|
2007
|
|
1 |
p. 120
|
artikel
|
| 42 |
Successful induction of immune tolerance by continuous infusion of recombinant factor VIII in a haemophilia A patient with high-inhibitor titres
|
TAMURA, K.
|
|
2006
|
|
1 |
p. 100-102
|
artikel
|
| 43 |
The Colorado Haemophilia Paediatric Joint Physical Examination Scale: normal values and interrater reliability
|
HACKER, M. R.
|
|
2007
|
|
1 |
p. 71-78
|
artikel
|
| 44 |
Topical use of tranexamic acid to control perioperative local bleeding in gynaecology patients with clotting disorders: two cases
|
SARRIS, I.
|
|
2007
|
|
1 |
p. 115-116
|
artikel
|
| 45 |
Von Willebrand disease within the collective of haemophilic patients as reason for unexpected bleeding episodes
|
SIEGMUND, B.
|
|
2007
|
|
1 |
p. 21-25
|
artikel
|
Tijdschrift beschrijving